Nanovector Assembled from Natural Egg Yolk Lipids for Tumor-Targeted Delivery of Therapeutics
Authors:
- 23 January 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (7) , 7984-7994
Abstract
Nanomedicine uses nanotechnology-based strategies for precision tumor therapy, including passive and ligand-mediated active tumor targeting by nanocarriers. However, the possible biotoxicity of chemosynthetic nanovectors limits their clinical applications. A novel natural egg yolk lipid nanovector (EYLNs) was developed for effective loading and delivery of therapeutic agents. Lipids were extracted from egg yolks and reassembled into nano-sized particles. EYLNs stability, cellular uptake, toxicity, and delivery capacity for therapeutic agents were evaluated in vitro. Systemic toxicity and biodistribution of EYLNs were analyzed in normal mice, and the therapeutic effects of doxorubicin (Dox)-loaded EYLNs were evaluated in mouse breast cancer and hepatoma models. EYLNs had a particle size of ~40 nm and a surface zeta potential of −45 mV and were effectively internalized by tumor cells, without showing toxicity and side effects in vitro and in vivo. Importantly, their excellent permeability and retention effect significantly enhanced the distribution of EYLNs to tumor sites, and EYLN-Dox effectively inhibited the tumor growth in both mouse models. Targeted modification with folic acid further promoted vector-mediated drug distribution in tumors. This study demonstrates that lipids with specific proportions in the egg yolk can be used to construct natural drug vectors, providing a new strategy for nano-oncology research.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20150421, BK20151287, BK20170455)
- National Natural Science Foundation of China (81572877, 81772585, 81800149, 81972739)
- Key Laboratory Projects of Huai?an, Jiangsu (HAP201606, HAP201804)
This publication has 57 references indexed in Scilit:
- Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cellsNature Protocols, 2013
- Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipidsNature Communications, 2013
- Can Controversial Nanotechnology Promise Drug Delivery?Chemical Reviews, 2012
- Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic NanomedicineAccounts of Chemical Research, 2011
- Silica and titanium dioxide nanoparticles cause pregnancy complications in miceNature Nanotechnology, 2011
- Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1βProceedings of the National Academy of Sciences, 2010
- Nanosized polyamidoamine (PAMAM) dendrimer-induced apoptosis mediated by mitochondrial dysfunctionToxicology Letters, 2009
- Unfolding of Ribonuclease A on Silica Nanoparticle SurfacesNano Letters, 2007
- The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome FormulationsDrug Delivery, 2004
- Doxorubicin in sterically stabilized liposomesNature, 1996